Comparative assessment of clinical trials, indications, pharmacokinetic parameters and side effects of approved platinum drugs
Platinum complexes are among the most commonly applied anticancer agents. The aim of current work is collection, analysing and comparative estimation of clinical trials and pharmacological indications of currently approved for application platinum detivatives: Cisplatin, Carboplatin, Oxaliplatin, Ne...
Saved in:
Main Author: | Stefka Ivanova (Author) |
---|---|
Format: | Book |
Published: |
Pensoft Publishers,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of chemical structure and mechanism of hydrolysis on pharmacological activity and toxicological profile of approved platinum drugs
by: Danka Obreshkova, et al.
Published: (2022) -
Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs
by: Zhiying Qin, et al.
Published: (2020) -
Platinum(IV) Complexes of the 1,3,5-Triamino Analogue of the Biomolecule Cis-Inositol Designed as Innovative Antineoplastic Drug Candidates
by: Vyara Velcheva, et al.
Published: (2022) -
Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters
by: V. B. Vasilyuk, et al.
Published: (2024) -
Specificity of clinical trials of some osteoporosis medicines
by: Stefka Ivanova, et al.
Published: (2022)